1.
Br J Dermatol
; 179(3): 787-789, 2018 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29624637
Assuntos
Adalimumab/uso terapêutico , MicroRNAs/sangue , Psoríase/tratamento farmacológico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab/farmacologia , Adulto , Idoso , Biomarcadores/sangue , Biomarcadores/metabolismo , Estudos de Casos e Controles , Epigênese Genética/efeitos dos fármacos , Estudos de Viabilidade , Feminino , Voluntários Saudáveis , Humanos , Leucócitos Mononucleares/metabolismo , Masculino , MicroRNAs/metabolismo , Pessoa de Meia-Idade , Psoríase/sangue , Psoríase/patologia , Pele/efeitos dos fármacos , Pele/patologia , Resultado do Tratamento , Adulto Jovem
2.
J Am Vet Med Assoc
; 200(7): 961-3, 1992 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-1577651
RESUMO
Serratia marcescens was the causative agent of bacterial endocarditis in a 2-year-old Arabian stallion. The horse was treated with broad-spectrum antibiotics for 1 month. The horse died several months after treatment was discontinued. To our knowledge, Serratia marcescens has not been reported as the cause of bacterial endocarditis in horses; however, multiple cases of bacterial endocarditis attributable to Serratia marcescens have been documented in human beings. The bacteria is most commonly isolated in immune-compromised patients.